156 related articles for article (PubMed ID: 17906287)
1. Glutamine tract length of human androgen receptors affects hormone-dependent and -independent prostate cancer in mice.
Albertelli MA; O'Mahony OA; Brogley M; Tosoian J; Steinkamp M; Daignault S; Wojno K; Robins DM
Hum Mol Genet; 2008 Jan; 17(1):98-110. PubMed ID: 17906287
[TBL] [Abstract][Full Text] [Related]
2. Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice.
Albertelli MA; Scheller A; Brogley M; Robins DM
Mol Endocrinol; 2006 Jun; 20(6):1248-60. PubMed ID: 16601069
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor variants and prostate cancer in humanized AR mice.
Robins DM; Albertelli MA; O'Mahony OA
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):230-6. PubMed ID: 17936615
[TBL] [Abstract][Full Text] [Related]
4. Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal.
Memarzadeh S; Cai H; Janzen DM; Xin L; Lukacs R; Riedinger M; Zong Y; DeGendt K; Verhoeven G; Huang J; Witte ON
Proc Natl Acad Sci U S A; 2011 May; 108(19):7962-7. PubMed ID: 21518863
[TBL] [Abstract][Full Text] [Related]
5. Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.
Higgins J; Brogley M; Palanisamy N; Mehra R; Ittmann MM; Li JZ; Tomlins SA; Robins DM
Horm Cancer; 2015 Jun; 6(2-3):67-86. PubMed ID: 25631336
[TBL] [Abstract][Full Text] [Related]
6. Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.
Shin S; Kim TD; Jin F; van Deursen JM; Dehm SM; Tindall DJ; Grande JP; Munz JM; Vasmatzis G; Janknecht R
Cancer Res; 2009 Oct; 69(20):8102-10. PubMed ID: 19789348
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer.
Welsbie DS; Xu J; Chen Y; Borsu L; Scher HI; Rosen N; Sawyers CL
Cancer Res; 2009 Feb; 69(3):958-66. PubMed ID: 19176386
[TBL] [Abstract][Full Text] [Related]
8. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity.
Kokontis JM; Hsu S; Chuu CP; Dang M; Fukuchi J; Hiipakka RA; Liao S
Prostate; 2005 Dec; 65(4):287-98. PubMed ID: 16015608
[TBL] [Abstract][Full Text] [Related]
9. Profiling human androgen receptor mutations reveals treatment effects in a mouse model of prostate cancer.
O'Mahony OA; Steinkamp MP; Albertelli MA; Brogley M; Rehman H; Robins DM
Mol Cancer Res; 2008 Nov; 6(11):1691-701. PubMed ID: 19010817
[TBL] [Abstract][Full Text] [Related]
10. FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells.
Ni L; Yang CS; Gioeli D; Frierson H; Toft DO; Paschal BM
Mol Cell Biol; 2010 Mar; 30(5):1243-53. PubMed ID: 20048054
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor action in hormone-dependent and recurrent prostate cancer.
Agoulnik IU; Weigel NL
J Cell Biochem; 2006 Oct; 99(2):362-72. PubMed ID: 16619264
[TBL] [Abstract][Full Text] [Related]
12. Length of the human androgen receptor glutamine tract determines androgen sensitivity in vivo.
Simanainen U; Brogley M; Gao YR; Jimenez M; Harwood DT; Handelsman DJ; Robins DM
Mol Cell Endocrinol; 2011 Aug; 342(1-2):81-6. PubMed ID: 21664242
[TBL] [Abstract][Full Text] [Related]
13. Effect of a short CAG (glutamine) repeat on human androgen receptor function.
Ding D; Xu L; Menon M; Reddy GP; Barrack ER
Prostate; 2004 Jan; 58(1):23-32. PubMed ID: 14673949
[TBL] [Abstract][Full Text] [Related]
14. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mice bearing humanized androgen receptor genes (h/mAr) varying in polymorphism length.
Lindenmaier Z; Yee Y; Kinman A; Fernandes D; Ellegood J; Burton CL; Robins DM; Raznahan A; Arnold P; Lerch JP
Neuroimage; 2021 Feb; 226():117594. PubMed ID: 33248253
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor gene polymorphisms and alterations in prostate cancer: of humanized mice and men.
Robins DM
Mol Cell Endocrinol; 2012 Apr; 352(1-2):26-33. PubMed ID: 21689727
[TBL] [Abstract][Full Text] [Related]
17. Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence.
Libertini SJ; Tepper CG; Rodriguez V; Asmuth DM; Kung HJ; Mudryj M
Cancer Res; 2007 Oct; 67(19):9001-5. PubMed ID: 17909000
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
19. Stromal epigenetic dysregulation is sufficient to initiate mouse prostate cancer via paracrine Wnt signaling.
Zong Y; Huang J; Sankarasharma D; Morikawa T; Fukayama M; Epstein JI; Chada KK; Witte ON
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):E3395-404. PubMed ID: 23184966
[TBL] [Abstract][Full Text] [Related]
20. Paired box 2 upregulates androgen receptor gene expression in androgen-independent prostate cancer.
Ito S; Ueda T; Ueno A; Nakagawa H; Taniguchi H; Hongo F; Kamoi K; Okihara K; Kawauchi A; Miki T
FEBS J; 2014 Oct; 281(19):4506-18. PubMed ID: 25132193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
